Literature DB >> 18424666

Insight into the pathogenesis of chronic lymphocytic leukemia (CLL) through analysis of IgVH gene usage and mutation status in familial CLL.

Dalemari Crowther-Swanepoel1, Ruth Wild, Gabrielle Sellick, Martin J S Dyer, Francesca R Mauro, Robert J G Cuthbert, Viggo Jonsson, Estella Matutes, Claire Dearden, James Wiley, Stephen Fuller, Daniel Catovsky, Richard S Houlston.   

Abstract

To address the proposition that familial B-cell chronic lymphocytic leukemia (CLL) may exhibit a more restricted phenotype than sporadic CLL with respect to immunoglobulin gene usage or ontogenic development, we compared immunoglobulin (Ig) heavy chain variable region (VH) gene usage and IgVH mutation status in 327 patients with CLL from 214 families with 724 patients with sporadic cases. The frequency of mutated CLL was higher in familial CLL (P < .001), and there was evidence of intrafamilial concordance in mutation status (P < .001). The repertoire and frequency of IgVH usage was, however, not significantly different between familial and sporadic CLL. Furthermore, IgVH usage was not correlated between affected members of the same family. These observations provide evidence that familial CLL is essentially indistinguishable from sporadic CLL, favoring a genetic basis to disease development in general rather than a simple environmental etiology.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18424666     DOI: 10.1182/blood-2008-03-142349

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  10 in total

1.  The clinical significance of patients' sex in chronic lymphocytic leukemia.

Authors:  Daniel Catovsky; Rachel Wade; Monica Else
Journal:  Haematologica       Date:  2014-03-21       Impact factor: 9.941

Review 2.  Familial chronic lymphocytic leukemia.

Authors:  Lynn R Goldin; Susan L Slager; Neil E Caporaso
Journal:  Curr Opin Hematol       Date:  2010-07       Impact factor: 3.284

Review 3.  Familial chronic lymphocytic leukemia.

Authors:  Richard S Houlston; Daniel Catovsky
Journal:  Curr Hematol Malig Rep       Date:  2008-10       Impact factor: 3.952

Review 4.  Familial chronic lymphocytic leukemia: what does it mean to me?

Authors:  Susan L Slager; Neil E Kay
Journal:  Clin Lymphoma Myeloma       Date:  2009

5.  The molecular basis of familial chronic lymphocytic leukemia.

Authors:  Dalemari Crowther-Swanepoel; Richard S Houlston
Journal:  Haematologica       Date:  2009-05       Impact factor: 9.941

6.  Inherited susceptibility to chronic lymphocytic leukemia: evidence and prospects for the future.

Authors:  Jennifer R Brown
Journal:  Ther Adv Hematol       Date:  2013-08

Review 7.  Inherited predisposition to chronic lymphocytic leukemia.

Authors:  Jennifer R Brown
Journal:  Expert Rev Hematol       Date:  2008-10       Impact factor: 2.929

8.  Natural history of monoclonal B-cell lymphocytosis among relatives in CLL families.

Authors:  Susan L Slager; Mark C Lanasa; Gerald E Marti; Sara J Achenbach; Nicola J Camp; Fatima Abbasi; Neil E Kay; Celine M Vachon; James R Cerhan; James B Johnston; Timothy G Call; Kari G Rabe; Geffen Kleinstern; Nicholas J Boddicker; Aaron D Norman; Sameer A Parikh; Jose F Leis; Versha Banerji; Danielle M Brander; Martha Glenn; Alessandra Ferrajoli; Karen Curtin; Esteban Braggio; Tait D Shanafelt; Mary L McMaster; J Brice Weinberg; Curtis A Hanson; Neil E Caporaso
Journal:  Blood       Date:  2021-04-15       Impact factor: 22.113

9.  Risk of developing chronic lymphocytic leukemia is influenced by HLA-A class I variation.

Authors:  M C Di Bernardo; P Broderick; S Harris; M J S Dyer; E Matutes; C Dearden; D Catovsky; R S Houlston
Journal:  Leukemia       Date:  2012-07-02       Impact factor: 11.528

10.  Association of elevated serumfree light chains with chronic lymphocytic leukemia and monoclonal B-cell lymphocytosis.

Authors:  Alyssa I Clay-Gilmour; Abdul R Rishi; Lynn R Goldin; Alexandra J Greenberg-Worisek; Sara J Achenbach; Kari G Rabe; Matthew J Maurer; Neil E Kay; Tait D Shanafelt; Timothy G Call; J Brice Weinberg; Nicola J Camp; James R Cerhan; Jose Leis; Aaron Norman; David L Murray; S Vincent Rajkumar; Neil E Caporaso; Ola Landgren; Mary L McMaster; Susan L Slager; Celine M Vachon
Journal:  Blood Cancer J       Date:  2019-08-05       Impact factor: 11.037

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.